Keeping oncologists current with CDK4/6 inhibitors in HR+ breast cancer: The impact of online education.

e13044Background: CDK4/6 inhibitors have revolutionized the care of patients with hormone receptor positive (HR+), HER2-negative breast cancer, improving survival outcomes. There are multiple CDK4/...